World Health Organization Prequalification
Found 5 free book(s)
MODULE I QUALITY ASSURANCE IN PROCUREMENT
www.ghsupplychain.orgcertificate and/or inspection report issued by the WHO Prequalification Team: Medicines (PQTm), an SRA, a Pharmaceutical Inspection Co-operation Scheme (PIC/S) member ... information for health care providers and end users should be provided in the appropriate ... 1 World Health Organization. n.d. WHO Model List of Essential Medicines.Geneva ...
Annex 10 - ICH
database.ich.org309 Annex 10 Stability testing of active pharmaceutical ingredients and finished pharmaceutical products Introduction and background The guidance on Stability testing of active pharmaceutical ingredients and finished pharmaceutical products was published as Annex 2 in the World Health Organization (WHO) Technical Report Series, No. 953, 2009 (1).The aim of these regulatory …
Product Information Report: Amoxicillin
www.usp-pqm.org[4]. The World Health Organization (WHO) recommends administering amoxicillin for childhood pneumonia in the form of 250 mg dispersible tablets [5]. Amoxicillin is an antibiotic with broad spectrum antimicrobial activity. It is currently marketed by multiple pharmaceutical companies in US in various dosage forms. There
COVID-19 VACCINES AND CORRUPTION RISKS: PREVENTING ...
www.unodc.orgThe World Health Organization (WHO) declared the outbreak of a new coronavirus SARS-CoV-2 (COVID-19) a pandemic on 11 March 2020. Since then, the pandemic continues to rage, and morbidity and mortality rates continue to climb globally. This illuminates the urgency of developing and ensuring access to affordable, safe and efficacious
Status of COVID-19 Vaccines within WHO EUL/PQ evaluation ...
extranet.who.intMedicago COVIFENZ® Health Canada P lant -based virus -like particle [VLP], recombinant, adjuvanted . Not accepted 31. Zorecimeran (INN) concentrate and solvent for dispersion for injection; Company code: CVnCoV/CV07050101 EMA m RNA -based vaccine encapsulated in lipid nanoparticle (LNP) Application withdrawn by ...